Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fazer research: The majority of Finns wish to see more kindness in the world

This year, the beloved Karl Fazer Milk Chocolate celebrates its 100th anniversary. To mark the occasion, Fazer charted Finns’ views on kindness. According to the study*, Finns do and experience kind deeds in their daily life but more kindness is needed.“Kindness is an important theme for Karl Fazer Milk Chocolate because if not for a friendly favour, this beloved milk chocolate wouldn’t exist,” says Markus Hellström, Managing Director at Fazer Confectionery. According to the study commissioned by Fazer and conducted by IRO Research, 88% of Finns believe that the world needs more kindness.

Change in number of shares and votes in Sleep Cycle

The number of shares and votes in Sleep Cycle AB (publ) have changed because of warrants being exercised as part of the warrant program 2019/2022.The number of shares and votes in Sleep Cycle AB (publ) have during August 2022 increased by 848 992 shares and votes as a result of warrants being exercised as part of the warrant program 2019:2022. As of August 31, 2022, there are thus in total 20 277 563 shares and votes in the company. The share capital has increased by approximately SEK 23 583, from SEK 539 683 to SEK 563 266. This is information that Sleep Cycle AB (publ) is obliged to

Caverion delivers building systems for two new faculty buildings at the University of Hamburg in Germany

Caverion Corporation Investor news 31 August 2022 at 10.00 a.m. EESTCaverion and the public contractor GMH Gebäudemanagement have signed an agreement for the construction of two new buildings for the Faculty of Mathematics, IT and Science (MIN) at the University of Hamburg in Germany. Caverion will deliver electricity and heating installations for the new buildings, the MIN Forum and the new building for IT. The value of the agreement is approximately EUR 9.3 million. Lecture halls, seminar rooms, a library and cafeteria are being built on a gross floor area of around 19,500 square

Alleima trading on Nasdaq Stockholm commences today

The shares of Alleima, a global manufacturer of advanced stainless steels, special alloys and heating systems for the most demanding industries, commence trading on Nasdaq Stockholm today. This marks the start of Alleima as a fully independent company after being part of Sandvik. The name Alleima is a combination of the words ”alloy” and ”material” – two core strengths of the company.[A picture containing text, building, outdoor, city Description automatically generated] “This is a historic day for our company and an important step to build for the future. We are the result of nearly

Rejlers wins assignment for Heimstaden in sustainable buildings

Rejlers has been commissioned by the real estate company Heimstaden to audit more than 30 properties from an energy and sustainability perspective. The mapping aims to identify measures to improve the properties' energy performance and reduce climate emissions, to achieve the company's high environmental goals.Heimstaden is a leading European residential real estate company with more than 150,000 homes in nine countries. The goal of the audit is to identify the measures required to achieve Heimstaden's high goals regarding energy performance and emissions. “Our mission is to find

Volvo Cars appoints Johan Ekdahl as CFO

Volvo Cars has appointed Johan Ekdahl as Chief Financial Officer, effective September 1, 2022. He has been Volvo Cars’ acting CFO since June this year when he succeeded Björn Annwall who took up a new position as Chief Commercial Officer & Deputy CEO. Johan joined Volvo Cars in 2015 and has led global accounting and group reporting in the company since 2017. “Johan is a strong leader who combines financial expertise with in-depth knowledge of our business. His background and experience will be crucial in his role as CFO to help us accelerate towards our strategic ambitions and become

Alleima trading on Nasdaq Stockholm commences today

The shares of Alleima, a global manufacturer of advanced stainless steels, special alloys and heating systems for the most demanding industries, commence trading on Nasdaq Stockholm today. This marks the start of Alleima as a fully independent company after being part of Sandvik. The name Alleima is a combination of the words ”alloy” and ”material” – two core strengths of the company. “This is a historic day for our company and an important step to build for the future. We are the result of nearly 160 years of collective minds, working together with our customers. Today Alleima is a

Resolutions of Toivo Group Plc’s Extraordinary General Meeting 31 August 2022

Toivo Group Plc, Company release 31 August 2022 at 10 a.m. The Extraordinary General Meeting of Toivo Group Plc (the “Company”) was held today on 31 August 2022 in Helsinki, Finland. The General Meeting adopted the following decisions: Members of the Board of Directors The number of the members of the Board of Directors was confirmed to be five (5). Jonna Toikka was elected as new board member. Amendment of the Articles of Association The General Meeting decided that the Company’s Articles of Association be amended by adding a new clause no. 11 which reads in its entirety

Contract awards for CSVs

Solstad Offshore ASA is pleased to announce awards of four new contracts for its subsea construction vessels (CSV). The contracts have a combined firm utilization of 410 days, with additional options thereafter, on projects in North Europe, West Africa and Asia. The contracts have a combined value of approximately NOK 260 million including addition services, such as ROV’s, “Walk to Work”-systems and project support. The majority of work will be executed during 4Q 2022 and 1Q 2023 by the CSVs Normand Australis, Normand Fortress, Normand Frontier and Normand Navigator. The clients are

Biosergen publishes interim report for second quarter 2022

Wednesday, August 31, 2022: Biosergen AB (“Biosergen” or the “Company”) thereby publishes the interim report for the second quarter 2022. The interim report is available as an attached document and on the company website (www.biosergen.net)Summary of the Interim Report for Q2 2022 2022 2021 2022 2021 2021TSEK April-June April-June Jan-June Jan-June Jan-Dec Consolidated group 1.409 2.001 2.726 2.001 11.570revenueConsolidated group -7.963 -9.493 -12.981 -17.798 -34.

Wyld Networks’ Interim Report Q2 2022: Scaling up to full commercial launch

Wyld continue to sign strategic launch partners, build on the purchase order book and successfully complete end-to-end testing of the satellite IoT network.CEO Alastair Williamson: “In Q2 Wyld’s development team finished the end-to-end testing of the satellite network. We have become the world’s first company to successfully connect a terminal integrated with Semtech’s LR-FHSS (long-range frequency hopping spread spectrum) chip directly to a low earth orbiting satellite. Wyld is now scaling up ahead of the full commercial launch later this year. Our business development team has been

Change of number of shares and votes in Rejlers

During the month of July, convertible bonds issued in Rejlers' convertible program for 2019 were converted to 233,220 Series B shares. As a result thereof, the number of shares and votes in Rejlers has changed. The number of shares in Rejlers today, the last trading day of the month, amounts to 20,381,849 shares, whereof 1,749,250 shares of series A and 18,632,599 shares of series B. The total number of votes in Rejlers amounts to 36,125,099. For further information, please contact:   Anna Jennehov, CFO, +46 73-074 06 70, anna.jennehov@rejlers.se This is information that Rejlers

Interim report May – Jul 2022: Steady sales growth fuelled by increased market penetration in the US

The period May 1[st] 2022 – JUl 31[st] 2022 · Net sales amounted TSEK 17 235 (12 882), which is an increase of 34% compared with the corresponding period last year. Strong growth of 45% in the US market, compared with the corresponding period last year. · Operating profit amounted to TSEK 366 (1 247) · Net profit amounted to TSEK -550 (1 282) · Cashflow from operating activities amounted to TSEK -13 030 (-8 553),-4.8 MDR project and -12.8 Accounts Receivables, respectively. · Earnings per share amounted to -0.03 SEK (0.08) Significant events in the period · The

The board of Bioservo resolves on a guaranteed preferential issue of units of approximately SEK 30.3 million conditional on the approval of an extraordinary general meeting

The board of Bioservo Technologies Aktiebolag (publ) ("Bioservo" or the "Company") has today resolved on an issue of units, consisting of shares and warrants with preferential rights for existing shareholders (the "Rights Issue"). In the case of full subscription in the Rights Issue, Bioservo will initially receive approximately SEK 30.3 million before issuing costs, and if all warrants are fully exercised, Bioservo can receive an additional approximately SEK 30.3 million before issuing costs. The Rights Issue requires the approval at an extraordinary general meeting on September 19, 2022.

Interim report January – June 2022

The period in summary First half year January 1 – June 30, 2022 –      On March 23 the first batch of Strangvac was released for sale in Sweden, and in the end of May we passed another milestone in the fight against strangles when Strangvac was released for sale in Denmark. –      On April 25 we announced positive results from a proof-of-concept study where piglets from vaccinated sows were protected against experimental challenge with Streptococcus suis. –      Progress in development of vaccine to prevent mastitis in dairy cows caused by Staphylococcus aureus. –      During

DanCann Pharma A/S intends to resolve on a partially (77 percent) guaranteed rights issue of approximately DKK 28.5 million

COPENHAGEN, Denmark, August 31, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Board of Directors in DanCann Pharma today announces its intention to resolve on a partially (77 percent) guaranteed rights issue of units corresponding to a total of approximately DKK 28.5 million (the “Rights Issue”). An Extraordinary General Meeting (“EGM”) is proposed to authorize the Board of Directors to resolve on the Rights Issue. The EGM is planned to be held on 20 September 2022 and the notice will be published

Orthex Corporation: Managers’ Transactions – Markus Hellström

Orthex Corporation, Managers’ transactions, 31 August 2022 at 9.30 a.m. EEST_______________________________________Person subject to the notification requirementName: Markus HellströmPosition: Member of the BoardIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION_______________________________________Transaction date: 2022-08-30Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 1,500 Unit price: 5.14 EURAggregated transactions(1)

Stayble Therapeutics reaches important milestone - phase IIb-study fully recruited

Stayble Therapeutics AB ("Stayble" or the "Company") announces today that the last patient has been recruited in the ongoing phase IIb clinical trial of STA363 for chronic disc-related low back pain. Recruitment is thereby completed. The patients will be followed for 12 months after inclusion. Final results from the study are expected to be available in Q4 2023 after the Company has compiled and analyzed data from all treated patients in the study.The primary objective of the study is to investigate the effect of STA363 on ongoing pain (primary endpoint) in patients suffering from chronic

BioStock: Saniona receives heightened interest in Q2

During 2022, Danish biotech Saniona has initiated restructuring measures that are expected to reduce future operating expenses by up to 75 per cent. Meanwhile, the company has seen a sharp increase in interest from over 50 companies that now have carried out evaluations on one or more of Saniona’s preclinical or clinical pipeline programmes.Read the article about Saniona at biostock.se: https://www.biostock.se/en/2022/08/saniona-receives-heightened-interest-in-q2/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Sectra extends medical diagnostics business to include genomics IT

Linköping, Sweden – August 31, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) is initiating a new business unit to drive innovation and product development within the area of genomics. In the future, Sectra’s enterprise diagnostic IT platform will be extended to efficiently handle genomics information—a further step in Sectra’s drive towards integrated diagnostics. This multidisciplinary approach is particularly important in cancer care.“Genetic information is becoming increasingly important in diagnostics and precision medicine,

Correction: Dentalum Operations AB (publ) half year report, January -June 2022

In the interim report published yesterday, errors were found regarding the company's cash flow statements and pro forma net leverage ratio. The The Group's cash flow for the second quarter amounts to SEK -46,709 thousand and the parent company's cash flow for the same period amounts to SEK -34,565 thousand. The pro forma net leverage ratio for the period LTM 06/22 amounts to 2.7. The corrected report is attached in its entirety.Maintained profitability and continued growth Second quarter, April - June 2022 · Operating revenue increased by 72.8 % to SEK 85.8 million (49.7). ·

Biosergen receives a loan of SEK 7 million to finance continued development

August 31, 2022: Biosergen AB (“Biosergen” or the “Company”) announces that it has entered into a loan agreement of SEK 7 million (the “Loan”). The Loan will be used to continue the development of BSG005 in accordance with existing plans until the end of 2022. Longer term funding solutions will be evaluated and decided at a later moment.The Loan is issued by Biosergens largest shareholder Östersjöstiftelsen (the “Lender”). The main  terms of the Loan are as follows: · The Lender agrees to lend to the Company a maximum total principal amount of SEK  7,000,000 (seven million Swedish

Thailand kicks off for winter with Amazing Thailand New Chapters Roadshow in Denmark and Stockholm

Amazing Thailand New Chapters Roadshow to Nordic & Baltic 2022 is Tourism Authority of Thailand very first roadshow in the Nordic region after the pandemic. Over 40 participants from travel agencies, charters and airlines from the Nordic and Baltic market joined the Amazing Thailand Roadshow to meet 18 representatives from hotels and destination management companies from Thailand. The events took place in Denmark on August 23 and in Stockholm on August 24. (Participants from travel agencies, charters and airlines from the Nordic and Baltic market and 18

Ratos AB – change in number of shares and votes

The third opportunity to exercise warrants according to the incentive program for the CEO and other key personnel in Ratos decided on by the 2018 Annual General Meeting and the first opportunity to convert convertible debentures into shares according to the incentive program for the CEO and other key personnel in Ratos decided on by the 2019 Annual General Meeting was completed in August 2022. Through the exercise of 40,000 warrants and conversion of 738,800 convertible debentures, the number of Class B shares increased by 778,800 and the number of votes by 77,880. After the increase, the

There are no items matching the current filter
There are no more items matching the current filter
Back to top